肝功能和肾功能异常患者对全剂量美诺加里尔（NSC 269148）的耐受性。 - Suppr

Suppr

超能文献

Tolerance of full dose menogaril (NSC 269148) in patients with abnormal hepatic and renal function.

作者信息

Conley B A, Egorin M J, Sinibaldi V, Van Echo D A

机构信息

Division of Development Therapeutics, University of Maryland Cancer Center, Baltimore.

出版信息

Invest New Drugs. 1990 Nov;8(4):365-7. doi: 10.1007/BF00198592.

DOI:10.1007/BF00198592

PMID:2150671

Abstract

摘要

相似文献

Tolerance of full dose menogaril (NSC 269148) in patients with abnormal hepatic and renal function.肝功能和肾功能异常患者对全剂量美诺加里尔（NSC 269148）的耐受性。

Invest New Drugs. 1990 Nov;8(4):365-7. doi: 10.1007/BF00198592.

Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group.静脉注射美诺加 ril 治疗晚期卵巢癌的 II 期研究。欧洲癌症研究与治疗组织早期临床试验组。

Eur J Cancer Clin Oncol. 1989 Apr;25(4):751-2. doi: 10.1016/0277-5379(89)90214-9.

Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group study.美诺加 ril 治疗胰腺腺癌的 II 期试验。西南肿瘤协作组的一项研究。

Invest New Drugs. 1991 Feb;9(1):77-8. doi: 10.1007/BF00194550.

Menogaril in the treatment of relapsed multiple myeloma. A phase II trial of the Cancer Center of Wake Forest University.美诺立尔治疗复发多发性骨髓瘤。维克森林大学癌症中心的一项II期试验。

Invest New Drugs. 1992 Apr;10(1):35-7. doi: 10.1007/BF01275478.

Phase II trial of menogaril in advanced colorectal cancer.美诺加 ril 用于晚期结直肠癌的 II 期试验。

Invest New Drugs. 1988 Sep;6(3):227-30. doi: 10.1007/BF00175404.

Phase I study of weekly intravenous administration of menogaril to adults with solid tumors.

Am J Clin Oncol. 1989 Dec;12(6):511-8. doi: 10.1097/00000421-198912000-00011.

Phase I trial of menogaril administered as an intermittent daily infusion for 5 days.美诺加里尔每日间歇输注5天的I期试验。

Cancer Treat Rep. 1986 Jun;70(6):721-5.

Phase I study of intravenous menogaril administered intermittently.静脉间歇注射美诺加里尔的I期研究。

J Clin Oncol. 1986 May;4(5):767-74. doi: 10.1200/JCO.1986.4.5.767.

Phase I study of oral menogaril administered on a once weekly schedule.口服美诺加 ril 每周给药一次的 I 期研究。

Invest New Drugs. 1990 Feb;8(1):43-52. doi: 10.1007/BF00216923.

A phase I study of menogaril in patients with advanced cancer.美诺加 ril 用于晚期癌症患者的 I 期研究。

J Clin Oncol. 1987 Jan;5(1):92-9. doi: 10.1200/JCO.1987.5.1.92.

本文引用的文献

The disposition of the new anthracycline antibiotic, menogarol, in mice.新型蒽环类抗生素美诺加罗在小鼠体内的处置情况。

Drug Metab Dispos. 1984 May-Jun;12(3):365-70.

Phase II study of intravenous menogaril in patients with advanced breast cancer.静脉注射美诺加ril治疗晚期乳腺癌患者的II期研究。

J Natl Cancer Inst. 1988 Sep 7;80(13):1066-9. doi: 10.1093/jnci/80.13.1066.

Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunction.美诺加里尔（NSC 269148）在肝功能不全患者中的I期研究及药代动力学

Cancer Res. 1987 Nov 15;47(22):6104-10.

Phase I trial of menogaril administered as an intermittent daily infusion for 5 days.美诺加里尔每日间歇输注5天的I期试验。

Cancer Treat Rep. 1986 Jun;70(6):721-5.

Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities.蒽环类抗生素美诺立尔（7-OMEN，NSC 269148）的人体药代动力学、排泄及代谢及其与临床毒性的相关性。

Cancer Res. 1986 Mar;46(3):1513-20.

Metabolism and disposition of menogaril (NSC 269148) in the rabbit.美诺加里尔（NSC 269148）在兔体内的代谢与处置

Cancer Res. 1985 Nov;45(11 Pt 1):5352-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验